Last deal

$3.58M
Local Amount - EUR 3.12M

Amount

Grant

Stage

01.01.2019

Date

3

all rounds

$36.08M

Total amount

date founded

Financing round

General

About Company
Regentis Biomaterials develops proprietary hydrogels for tissue regeneration.

Industry

Sector :

Subsector :

founded date

01.01.2004

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The company's core technology is a degradable hydrogel called Gelrin™, which combines the stability and versatility of a synthetic material with the bio-functionality of a natural substance, and is designed for a range of clinical applications. Regentis Biomaterials' flagship product, GelrinC™, is currently in clinical trials and is an off-the-shelf implant for the treatment of painful injuries to articular knee cartilage, offering clinicians a high likelihood of successful treatment.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Gentis

Gentis

Gentis develops biomaterials-based products for early-stage degeneration of the spine.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical Device

Location

Wayne, PA, USA

total rounds

2

total raised

$10.55M
Biotrics Bioimplants

Biotrics Bioimplants

Biotrics Bioimplants develops biomaterials for oral tissue regeneration.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Life Science, Biotechnology, Manufacturing

Location

Zossen, Germany
BioChange Ltd.

BioChange Ltd.

BioChange has developed an injectable scaffold that stimulates tissue repair and regeneration.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Yokne'am Illit, Israel

total rounds

1
Spiderwort

Spiderwort

Spiderwort is a tissue engineering company that develops transformative biomaterials for repairing and regenerating human tissues.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Ottawa, ON, Canada

total rounds

5

total raised

$16.08M

Financials

Funding Rounds
5
3

Number of Funding Rounds

$36.08M

Money Raised

Their latest funding was raised on 01.01.2019. Their latest investor ProSeed Venture Capital Fund. Their latest round Grant

Date 
Funding Round 
Investors 
Money Raised 
Lead 
01.01.2019
1
$3.58M
Local Amount - EUR 3.12M
07.02.2016
5
$15M
14.05.2012
3
$10M
Haisco

Haisco

Haisco Pharmaceutical Group is a Chinese healthcare company that develops therapeutic drugs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Liaoning, China

count Of Investments

6

count Of Exists

1
Co-Investors
Investors
8
2

Number of lead investors

8

Number of investors

Investor 
Lead 
Round 
Partners 
ProSeed Venture Capital Fund

ProSeed Venture Capital Fund

ProSeed VC funds and supports early-stage tech companies in Israel.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services

Location

Tel Aviv-Yafo, Israel

count Of Investments

19

count Of Exists

2
DSM Venturing

DSM Venturing

Royal DSM Venturing is investing in startups in animal and human health and nutrition and biomed sectors.

Sector

General Industrials

Subsector

Diversified Industrials

Location

Heerlen, Netherlands

count Of Investments

82

count Of Exists

10
EASME - EU Executive Agency for SMEs

EASME - EU Executive Agency for SMEs

EASME manages EU programs for SMEs, environment, energy, and maritime projects.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Energy, Project Management

Location

Brussels, Belgium

count Of Investments

3607

count Of Exists

165

People

Founders
1
Dror Seliktar
Dror Seliktar

Dror Seliktar

Prof. Seliktar brings 14 years of biomaterials and tissue engineering research experience in American, European, and Israeli Academic Institutions. Prior to joining the Biomedical Engineering Department at the Technion, Prof. Seliktar was an N.S.F. International Postdoctoral Research Fellow in the Department of Materials at the Swiss Federal Institute of Technology, Zurich, Switzerland (ETH). Prof. Seliktar holds a Bachelor’s degree in Mechanical Engineering from Drexel University (Summa Cum Laude), Philadelphia, PA, and a Master’s degree in Mechanical Engineering and a Ph.D. in Biomedical Engineering from the Georgia Institute of Technology, Atlanta, Georgia, USA.

current job

Regentis Biomaterials
Regentis Biomaterials

organization founded

1

Dror Seliktar

Employee Profiles
4
Menashe Levy

Menashe Levy

Vice President

Dror Seliktar

Dror Seliktar

CSO and Co-Founder

Alastair J. Clemow

Alastair J. Clemow

President and CEO

Activity

Recent News
2
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month